BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22654667)

  • 41. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
    Griesing S; Kajino T; Tai MC; Liu Z; Nakatochi M; Shimada Y; Suzuki M; Takahashi T
    Cancer Sci; 2017 Jul; 108(7):1394-1404. PubMed ID: 28474808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
    Liu Y; Mayo MW; Xiao A; Hall EH; Amin EB; Kadota K; Adusumilli PS; Jones DR
    Mol Cell Biol; 2015 Jan; 35(1):303-17. PubMed ID: 25368381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF.
    Cisowski J; Sayin VI; Liu M; Karlsson C; Bergo MO
    Oncogene; 2016 Mar; 35(10):1328-33. PubMed ID: 26028035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.
    Fan J; Fan Y; Wang X; Niu L; Duan L; Yang J; Li L; Gao Y; Wu X; Luo C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):337. PubMed ID: 31383001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of TWIST1 in epithelial-mesenchymal transition and cancers.
    Zhu QQ; Ma C; Wang Q; Song Y; Lv T
    Tumour Biol; 2016 Jan; 37(1):185-97. PubMed ID: 26602382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twist1 is a key regulator of cancer-associated fibroblasts.
    Lee KW; Yeo SY; Sung CO; Kim SH
    Cancer Res; 2015 Jan; 75(1):73-85. PubMed ID: 25368021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation.
    Grasso D; Bintz J; Lomberk G; Molejon MI; Loncle C; Garcia MN; Lopez MB; Urrutia R; Iovanna JL
    Sci Rep; 2015 Nov; 5():17549. PubMed ID: 26617245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of Mutant
    Zhou X; Padanad MS; Evers BM; Smith B; Novaresi N; Suresh S; Richardson JA; Stein E; Zhu J; Hammer RE; O'Donnell KA
    Mol Cancer Res; 2019 Feb; 17(2):594-603. PubMed ID: 30409919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.
    Elsum IA; Yates LL; Pearson HB; Phesse TJ; Long F; O'Donoghue R; Ernst M; Cullinane C; Humbert PO
    Oncogene; 2014 Nov; 33(48):5523-33. PubMed ID: 24276238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
    Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
    J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.
    Best SA; Vandenberg CJ; Abad E; Whitehead L; Guiu L; Ding S; Brennan MS; Strasser A; Herold MJ; Sutherland KD; Janic A
    Cell Death Dis; 2020 Oct; 11(10):877. PubMed ID: 33082333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
    Nam EH; Lee Y; Moon B; Lee JW; Kim S
    Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
    Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
    Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation of the LXCXE binding cleft of pRb facilitates transformation by ras in vitro but does not promote tumorigenesis in vivo.
    Talluri S; Francis SM; Dick FA
    PLoS One; 2013; 8(8):e72236. PubMed ID: 23936539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
    Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
    Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of the transcription factor twist in phenotype alteration through epithelial-mesenchymal transition in lung cancer cells.
    Nakashima H; Hashimoto N; Aoyama D; Kohnoh T; Sakamoto K; Kusunose M; Imaizumi K; Takeyama Y; Sato M; Kawabe T; Hasegawa Y
    Mol Carcinog; 2012 May; 51(5):400-10. PubMed ID: 21594904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The interplay between microRNAs and Twist1 transcription factor: a systematic review.
    Khanbabaei H; Teimoori A; Mohammadi M
    Tumour Biol; 2016 Jun; 37(6):7007-19. PubMed ID: 26880587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis.
    Grabner B; Schramek D; Mueller KM; Moll HP; Svinka J; Hoffmann T; Bauer E; Blaas L; Hruschka N; Zboray K; Stiedl P; Nivarthi H; Bogner E; Gruber W; Mohr T; Zwick RH; Kenner L; Poli V; Aberger F; Stoiber D; Egger G; Esterbauer H; Zuber J; Moriggl R; Eferl R; Győrffy B; Penninger JM; Popper H; Casanova E
    Nat Commun; 2015 Mar; 6():6285. PubMed ID: 25734337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.
    Gou W; Zhou X; Liu Z; Wang L; Shen J; Xu X; Li Z; Zhai X; Zuo D; Wu Y
    Cancer Lett; 2018 May; 422():19-28. PubMed ID: 29477381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.